Analyst Research Report Snapshot

Title:

Astellas Pharma Inc.

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

13 Jan 2015

Pages:

50

Type:

AcrobatPDF

Companies referenced:

4503.T

Available for Immediate Download
Summary:

Astellas Pharma (Astellas or 'the company') is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company operates in Japan, other Asian countries, the Americas, Europe and other regions of the world. It is headquartered in Tokyo, Japan and employed 17,454 people as of March 31, 2013. The company recorded revenues of JPY1,005,612 million (approximately $12,167.9 million) during the financial year ended March 2013 (FY2013), an increase of 3.7% over FY2012. The operating profit of the company was JPY153,867 million (approximately $1,861.8 million) in FY2013, an increase of 17% over FY2012. The net profit was JPY82,851 million (approximately $1,002.5 million) in FY2013, an increase of 5.9% over FY2012

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.